Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation

NCT04811326 is registered in ClinicalTrials.gov with Shaimaa Fawzy Abdel-rady Abdel-latif as lead sponsor.

NCT NCT04811326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04811326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation
Lead sponsor
Shaimaa Fawzy Abdel-rady Abdel-latif
Phase
Phase 4
Overall status
Unknown status
Start date
January 13, 2021
Completion date
March 13, 2024
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-segmental vitiligo